Form 8-K - Current report:
SEC Accession No. 0001493152-25-000028
Filing Date
2025-01-02
Accepted
2025-01-02 09:15:09
Documents
16
Period of Report
2024-12-31
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 42159
2 ex10-1.htm EX-10.1 16381
3 ex10-1_001.jpg GRAPHIC 25526
4 ex10-1_002.jpg GRAPHIC 873
  Complete submission text file 0001493152-25-000028.txt   268140

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE otlc-20241231.xsd EX-101.SCH 3018
6 XBRL LABEL FILE otlc-20241231_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE otlc-20241231_pre.xml EX-101.PRE 24167
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3359
Mailing Address 29397 AGOURA RD. #107 AGUORA HILLS CA 91301
Business Address 29397 AGOURA RD. #107 AGUORA HILLS CA 91301 650-635-7000
Oncotelic Therapeutics, Inc. (Filer) CIK: 0000908259 (see all company filings)

EIN.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21990 | Film No.: 25500426
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)